Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Estrogenic substances

From Wikipedia, the free encyclopedia
Estrogen medication
Not to be confused withEstrogen (medication) orEstrone (medication).
Pharmaceutical compound
Estrogenic substances
Estrone, a major ingredient in estrogenic substances
Combination of
EstroneEstrogen
17β-EstradiolEstrogen
EquilinEstrogen
Clinical data
Trade namesAmniotin, Estrogenic Hormones, Estrogenic Substances, Estrolin, Estromone, Folestrin, Follacro, Menformon, Oestroform, Ova-Estrin, Theelestrin, others
Other namesNatural estrogens; Estrone-like preparations
Routes of
administration
By mouth (tablets,capsules),topical (ointment),vaginal (suppository),intramuscular injection (oil solution)
Drug classEstrogen
Legal status
Legal status

Estrogenic substances, also referred to asnatural estrogens and sold under the brand nameAmniotin among others, is anestrogen medication which was marketed in the 1930s and 1940s and is no longer available.[1][2][3][4][5][6] It was a purifiedextract ofanimal material such as horseurine,placenta, and/oramniotic fluid, and contained a non-crystallinemixture of estrogens, includingestrone,17β-estradiol,17α-estradiol, and/orequilin.[3][1][7][8][5][9] The medication was thought to contain estrone as its major active ingredient[7] and was described as an estrone-like preparation, or as "essentially estrone".[1][3][5] Estrogenic substances was originally produced from the urine of pregnant women, placenta, and/or amniotic fluid, but by the early 1940s, it was manufactured exclusively from the urine ofstallions or pregnantmares, similarly to almost all other estrogen preparations on the market.[8][9][7][1]

Estrogenic substances was marketed under a variety of different brand names includingAmniotin (Squibb),Equine Estrogenic Substances (Ayerst),Estrogenic Hormones (Upjohn, others),Estrogenic Substances (Reed & Carnrick, Sharp & Dohme, others),Estrolin (Lakeside),Estromone,Estronat (National Drug),Folestrin (Armour),Follacro (Schieffelin),Menformon (Roche-Organon),Neo-Amniotin (Squibb),Oestroform,Ova-Estrin,Theelestrin, andUrestrin (Upjohn), among others.[1][2][3][4][6] It was provided in variousforms androutes of administration includingoil solution andaqueous suspension forintramuscular injection,oraltablets andcapsules,vaginalsuppositories, andtopicalointments.[2][3][4][1][6]

Estrogen medications similar to but distinct from estrogenic substances includedconjugated estriol (Emmenin) andconjugated estrogens (Premarin).[1] They are also non-crystalline mixtures of estrogens.[1] Estrogenic substances were also distinct from pure crystalline preparations such asestrone,estradiol,estriol,estradiol benzoate, andestradiol dipropionate.[1] The medication should additionally be distinguished from estrogenovarian extracts, which had little activity and were considered to be essentially inactive.[10][2]

Progynon and Amniotin were both marketed by 1929.[11] Amniotin was originally prepared from the amniotic fluid of cattle, but was later prepared using other sources such as the urine of pregnant mares.[12][9]

References

[edit]
  1. ^abcdefghi"Nomenclature of Endocrine Preparations".Journal of the American Medical Association.123 (6): 351. 1943.doi:10.1001/jama.1943.02840410033009.ISSN 0002-9955.
  2. ^abcdFluhmann CF (November 1938)."Estrogenic Hormones: Their Clinical Usage".California and Western Medicine.49 (5):362–366.PMC 1659459.PMID 18744783.
  3. ^abcdeGreene RR (1941). "Endocrine Therapy for Gynecologic Disorders".Medical Clinics of North America.25 (1):155–168.doi:10.1016/S0025-7125(16)36624-X.ISSN 0025-7125.
  4. ^abcFluhmann CF (1944). "Clinical use of extracts from the ovaries".Journal of the American Medical Association.125 (1): 1.doi:10.1001/jama.1944.02850190003001.ISSN 0002-9955.
  5. ^abcReifenstein EC (1944). "Endocrinology: A Synopsis of Normal and Pathologic Physiology, Diagnostic Procedures, and Therapy".Medical Clinics of North America.28 (5):1232–1276.doi:10.1016/S0025-7125(16)36180-6.ISSN 0025-7125.
  6. ^abcGoldzieher MA, Goldzieher JW (1953).Endocrine Treatment in General Practice. Springer Publishing Company. pp. 436–.
  7. ^abcBarr DP (1940).Modern Medical Therapy in General Practice. William & Wilkins Company.ISBN 9780598668332.Complex Estrogenic Preparations. 1. Amniotin (Squibb). This is a highly purified but not crystalline preparation derived from pregnant mares' urine. The chief active ingredient is apparently ketohydroxyestrin (estrone).
  8. ^abGlandular Physiology and Therapy. American Medical Association. 1935. p. 480.Amniotin, E. R. Squibb & Sons: This is an estrogenic preparation originally derived from amniotic fluid; it is not reduced to the crystalline state during manufacture. More recently, according to the firm, the urine of pregnant mares has served as an added source of active material.
  9. ^abcMcCullagh EP (1935)."The Management of Functional Menstrual Disorders".Cleveland Clinic Quarterly.2 (4):52–64.doi:10.3949/ccjm.2.4.52.
  10. ^Novak E (1935). "The Therapeutic Use of Estrogenic Substances".JAMA: The Journal of the American Medical Association.104 (20): 1815.doi:10.1001/jama.1935.92760200002012.ISSN 0098-7484.
  11. ^The Female Sex Hormone. C.C. Thomas. 1929. p. 276.
  12. ^Biskind MS (1935). "Commercial glandular products".Journal of the American Medical Association.105 (9): 667.doi:10.1001/jama.1935.92760350007009a.ISSN 0002-9955.
Estrogens
ERTooltip Estrogen receptor agonists
Progonadotropins
Antiestrogens
ERTooltip Estrogen receptor antagonists
(incl.SERMsTooltip selective estrogen receptor modulators/SERDsTooltip selective estrogen receptor downregulators)
Aromatase inhibitors
Antigonadotropins
Others
ERTooltip Estrogen receptor
Agonists
Mixed
(SERMsTooltip Selective estrogen receptor modulators)
Antagonists
GPERTooltip G protein-coupled estrogen receptor
Agonists
Antagonists
Unknown
Retrieved from "https://en.wikipedia.org/w/index.php?title=Estrogenic_substances&oldid=1191750852"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp